Evidence review

KPV: Gut-Specific Anti-Inflammatory

#peptide#kpv
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `kpv`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/kpv

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/kpv/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/kpv/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/kpv/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/kpv/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

Regeneration vs degeneration — where this fits

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: KPV is studied for gut lining and inflammatory gut pathways — mucosal repair vs ongoing gut degeneration.

What it is

Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only. 2026 comprehensive review summarizing KPV mechanisms, benefits for inflammation/gut/wound healing, safety concerns, and lack of human trials.

How it works

Step logic:

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
  2. 2012 study on KPV's anti-inflammatory mechanism in bronchial epithelial cells via MC3R.
  3. The disclaimer is a required constitution slot and does not require sourcing, as it is a standard statement on research catalogues.
  4. 2017 study on transdermal delivery of KPV for potential skin inflammation treatment.
  5. 2026 paper on new oral delivery system for KPV and other peptides in inflammatory conditions.
  6. KPV is transported into intestinal epithelial and immune cells via the PepT1 transporter and inhibits NF-κB and MAP kinase pathways.
  7. 2024 study on self-assembled KPV-RAPA nanoparticles for vascular calcification, showing anti-inflammatory effects.
  8. 2018 research on modifying KPV tripeptide for improved stability, showing parent KPV degrades quickly.

Why it would work (logic chain)

  1. IF Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  2. IF 2012 study on KPV's anti-inflammatory mechanism in bronchial epithelial cells via MC3R. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  3. IF The disclaimer is a required constitution slot and does not require sourcing, as it is a standard statement on research catalogues. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  4. IF 2017 study on transdermal delivery of KPV for potential skin inflammation treatment. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  5. IF 2026 paper on new oral delivery system for KPV and other peptides in inflammatory conditions. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  6. IF KPV is transported into intestinal epithelial and immune cells via the PepT1 transporter and inhibits NF-κB and MAP kinase pathways. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).

Why people take it

Reasons that appear in this ledger:

  1. X post highlighting KPV's anti-inflammatory benefits without full alpha-MSH side effects.
  2. Italian X post promoting KPV for IBS, diverticula, gut inflammation, claiming superior to cortisone in animal models. (anecdotal/promotional).
  3. X post describing KPV as effective, well-tolerated gut anti-inflammatory in personal stack. (anecdotal, not advice).
  4. X user recommends KPV based on knowing multiple people helped with gut/bowel issues like Crohn's/IBS.
  5. User mentions ongoing personal use in stack; anecdotal positive (anecdotal, not advice).
  6. Detailed user/research guide post on Reddit explaining KPV mechanisms, benefits, dosing, and research status (anecdotal/community info).
  7. 2025/2026 YouTube video discussing KPV benefits for inflammation and gut health with user anecdotes in comments.
  8. User anecdotes on KPV subQ use for gut pain, dermatitis, energy; benefits reversed after stopping.
  9. Video discussing KPV science, benefits, and risks.
  10. User reports negative side effects from KPV including dizziness, sleep issues, headaches, brain fog, fatigue; others note it helped with MCAS inflammation or gut issues but some had to stop due to bad effects; mixed experiences with herx/die-off reactions.

How many people take it

There is no reliable global count of how many people take this compound. That number is not in this ledger.

What we can count from this ledger:

  • 64 anecdote source(s) (posts, threads, comments)
  • 64 anecdote-tier claim(s) derived from them

Logic: 64 online report(s) are catalogued here. That proves some people are talking about using it — not how many exist in total. Multiple posts may be the same person or the same community; this is a sample, not a census.

Evidence inventory

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 36
  • Claims tagged human evidence: 8
  • Claims tagged preclinical (animal/lab): 6
  • Claims tagged anecdotal: 64
  • Reddit posts catalogued: 50
  • X posts catalogued: 10
  • Other anecdote sources (YouTube, Instagram, etc.): 4
  • Total sources in chain: 103

Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation (source s1)

Human cell line and mouse colitis study on PepT1-mediated uptake and NF-kB inhibition.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease (source s2)

Mouse colitis model results.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation (source s3)

Confirms mouse model efficacy.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin (source s6)

2017 study on transdermal delivery of KPV for potential skin inflammation treatment.

Evidence type: Published research.

KPV Peptide | Benefits, Safety & Buying Advice [2026] (source s7)

2026 comprehensive review summarizing KPV mechanisms, benefits for inflammation/gut/wound healing, safety concerns, and lack of human trials.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Inflammation-triggered self-immolative conjugates enable oral delivery of anti-inflammatory peptides (source s8)

2026 paper on new oral delivery system for KPV and other peptides in inflammatory conditions.

Evidence type: Published research.

Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists (source s11)

2012 study on KPV's anti-inflammatory mechanism in bronchial epithelial cells via MC3R.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model (source s12)

2016 mouse study showing KPV via PepT1 prevents colitis-associated cancer.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis (source s13)

2017 study on HA-functionalized nanoparticles for targeted KPV delivery in UC mouse model.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

KPV tripeptide (source s14)

Wikipedia entry summarizing KPV as α-MSH fragment with anti-inflammatory properties and skincare use.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

KPV Peptide: Benefits, Dosage & 2026 Legal Status (source s15)

2026 article on KPV benefits, dosage, and updated FDA compounding legal status.

Evidence type: Published research.

KPV Peptide: Comprehensive Guide to Benefits, Dosage and ... (source s16)

2026 guide covering KPV chemistry, uses, and 2026 FDA review details.

Evidence type: Published research.

KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy (source s28)

2024 study on self-assembled KPV-RAPA nanoparticles for vascular calcification, showing anti-inflammatory effects.

Evidence type: Published research.

Bioactive peptides and proteins for tissue repair (source s29)

2024 review discussing KPV in tissue repair and wound healing contexts.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Is KPV Peptide Safe To Take? (source s30)

2026 medical overview on KPV safety, benefits for inflammation, gut, skin; emphasizes supervision.

Evidence type: Published research.

KPV Peptide: Anti-Inflammatory Mechanisms and Research (source s31)

2026 clinical overview of KPV mechanisms, origin from alpha-MSH, limited human data.

Evidence type: Published research.

Anti‐Inflammatory Peptides as Promising Therapeutics for Inflammatory Bowel Disease (source s35)

2025 review discussing KPV/K(D)PT in IBD, including references to clinical trials and anti-inflammatory potential.

Evidence type: Published research.

KPV: The Anti-Inflammatory Peptide Under FDA Review (source s38)

Article on KPV regulatory status in 2026 and preclinical evidence for inflammation/wound healing.

Evidence type: Published research.

What people say on Reddit

A Complete Guide for KPV — Reddit, r/Ameano_Peptides (source s9)

Detailed user/research guide post on Reddit explaining KPV mechanisms, benefits, dosing, and research status (anecdotal/community info).

Anyone here with experience using KPV or other peptides ... — Reddit, r/Biohackers (source s17)

User anecdotes on KPV subQ use for gut pain, dermatitis, energy; benefits reversed after stopping.

KPV Peptide Side Effects — Reddit, r/Longcovidgutdysbiosis (source s19)

User reports negative side effects from KPV including dizziness, sleep issues, headaches, brain fog, fatigue; others note it helped with MCAS inflammation or gut issues but some had to stop due to bad effects; mixed e….

KPV Peptide Side Effects — Reddit, r/Longcovidgutdysbiosis (source s20)

Positive user experience reducing MCAS inflammation and reactions quickly with daily KPV.

KPV peptides — Reddit, r/Longcovidgutdysbiosis (source s21)

User reports KPV helped gut repair after slow titration despite initial paradoxical reactions; emphasizes starting low and slow.

KPV peptides — Reddit, r/Longcovidgutdysbiosis (source s22)

Positive report of KPV improving histamine tolerance, with note on possible herx reaction at start.

Is anyone being helped by peptides? — Reddit, r/MCAS (source s23)

Strong positive experience with KPV reducing fatigue and improving food tolerance in MCAS context.

Is anyone being helped by peptides? — Reddit, r/MCAS (source s24)

User reports dramatic ~80% symptom reduction from KPV.

KPV fatigue and apathy — Reddit, r/Biohackers (source s25)

Negative side effects reported: fatigue and strong apathy from low-dose KPV.

How effective is KPV peptide? Is it really worth it? — Reddit, r/Biohackers (source s27)

Positive anecdotal report of KPV improving inflammation, skin, gut, and fungal issues like nail fungus and dandruff.

Best peptides and brands for MCAS ? BPC-157, KPV and ... — Reddit, r/MCAS (source s32)

2026 Reddit anecdotes on KPV for MCAS, mixed experiences including improvements and side effects like flushing.

KPV Explained Simply (The Gut Inflammation Fighter) — Reddit, r/PeptideProgress (source s33)

Recent Reddit post summarizing KPV use for gut inflammation, dosing, side effects.

KPV peptide guide — Reddit, r/NTNPerformance (source s36)

User guide on Reddit explaining KPV mechanism for gut and inflammation.

SS-31 and KPV peptides...what are your experiences? — Reddit, r/MCAS (source s41)

MCAS subreddit users discussing personal experiences with KPV for symptoms like fatigue and inflammation.

Kpv peptide — Reddit, r/Longcovidgutdysbiosis (source s42)

User anecdote on KPV for long COVID gut issues and MCAS reversal.

Massive worsening of symptoms after peptide usage? — Reddit, r/MCAS (source s43)

Anecdotal report of negative side effects from KPV in MCAS patient.

What people say on X

X post on KPV for nausea — X (source s62)

User shares positive anecdotal experience using KPV to quickly reduce nausea from other peptides like cagri.

Peptides will unleash the greatest consumer health wave ... — X (source s70)

X post discussing potential re-legalization of KPV and other peptides for compounding.

KPV peptide description — X (source s87)

X post highlighting KPV's anti-inflammatory benefits without full alpha-MSH side effects.

KPV S tier claim — X (source s88)

X post claiming strong positive results from KPV based on personal and client data.

KPV peptide post — X (source s91)

Italian X post promoting KPV for IBS, diverticula, gut inflammation, claiming superior to cortisone in animal models. (anecdotal/promotional).

KPV in stack — X (source s92)

X post describing KPV as effective, well-tolerated gut anti-inflammatory in personal stack. (anecdotal, not advice).

KPV recommendation — X (source s93)

X user recommends KPV based on knowing multiple people helped with gut/bowel issues like Crohn's/IBS. (anecdotal).

X post on KPV science — X (source s97)

Discussion of KPV mechanisms and research; no personal dosing anecdotes.

X post on KPV FDA and personal use — X (source s98)

User mentions ongoing personal use in stack; anecdotal positive (anecdotal, not advice).

X post preferring KPV — X (source s99)

Positive anecdotal preference for KPV over others; no specific side effects or dosing.

Other anecdote evidence

The Best Peptide for Inflammation, Gut Health, and Visceral Fat Loss (KPV Peptide) — YouTube (source s10)

2025/2026 YouTube video discussing KPV benefits for inflammation and gut health with user anecdotes in comments.

KPV Peptide - Miracle Cure or Major Risk? — YouTube (source s18)

Video discussing KPV science, benefits, and risks.

This Peptide “Fixes” Your Gut... But There's a Catch — YouTube (source s26)

YouTube comment sharing positive outcome: KPV (with other interventions) resolved IBS, Crohn's, celiac symptoms dramatically.

KPV: The Barrier Repair Peptide (Gut, Skin & Chronic Inflammation) — YouTube (source s37)

YouTube video discussing KPV science, benefits for gut/skin/inflammation with anecdotal mentions.

Safety and limits

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Kpv · peptide map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpBPC-157 and KPV for IBD, Crohn's Disease, and Colitis: Preclinical Evi… · 7 humanBPC-157 + KPV for Gut Lining Repair: Evidence Review · 3 humanBPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation… · 3 humanBenzo Withdrawal
Evidence · 103 sources · swipe →chain 3490badc045c · verify chain · provenance
1 / 103
Evidence ledger 97 · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
human
2026 comprehensive review summarizing KPV mechanisms, benefits for inflammation/gut/wound healing, safety concerns, and lack of human trials.
sources: s7
human
2012 study on KPV's anti-inflammatory mechanism in bronchial epithelial cells via MC3R.
sources: s11
human
2025 review discussing peptide strategies including KPV for IBD.
sources: s55
human
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
81 more ranked claims
preclinical0.50
In DSS- and TNBS-induced murine colitis models, oral KPV reduced histologic inflammation, disease activity, and cytokine expression
system/unknown
Primary animal data separating from human
sources: s2, s3
preclinical0.50
2016 mouse study showing KPV via PepT1 prevents colitis-associated cancer.
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
preclinical0.50
2017 study on HA-functionalized nanoparticles for targeted KPV delivery in UC mouse model.
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
preclinical0.50
2008 study showing KPV's anti-inflammatory effects via PepT1 transporter in intestinal cells and mouse colitis models, reducing pro-inflammatory cytokines.
grok/grok-4.3
Materialized from orphan source s77 by ledger repair
sources: s77
mechanistic0.40
The disclaimer is a required constitution slot and does not require sourcing, as it is a standard statement on research catalogues.
kimi/moonshot-v1-8k (adversary)
The claim is unsourced but is a standard disclaimer that does not need to be supported by external sources, as it is a common practice in research catalogues to include such disclaimers.
system0.35
KPV: Gut-Specific Anti-Inflammatory is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
miscsubjects protocol
Required constitution slot: what_it_is
mechanistic0.30
2017 study on transdermal delivery of KPV for potential skin inflammation treatment.
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
mechanistic0.30
2026 paper on new oral delivery system for KPV and other peptides in inflammatory conditions.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.30
X post highlighting KPV's anti-inflammatory benefits without full alpha-MSH side effects.
grok-4.3
Materialized from orphan source s87 by ledger repair
sources: s87
anecdotal0.30
Italian X post promoting KPV for IBS, diverticula, gut inflammation, claiming superior to cortisone in animal models. (anecdotal/promotional)
grok-4.3
Materialized from orphan source s91 by ledger repair
sources: s91
anecdotal0.30
X post describing KPV as effective, well-tolerated gut anti-inflammatory in personal stack. (anecdotal, not advice)
grok-4.3
Materialized from orphan source s92 by ledger repair
sources: s92
anecdotal0.30
X user recommends KPV based on knowing multiple people helped with gut/bowel issues like Crohn's/IBS. (anecdotal)
grok-4.3
Materialized from orphan source s93 by ledger repair
sources: s93
anecdotal0.30
User mentions ongoing personal use in stack; anecdotal positive (anecdotal, not advice).
grok-4.3
Materialized from orphan source s98 by ledger repair
sources: s98
human0.22low confidence
Wikipedia entry summarizing KPV as α-MSH fragment with anti-inflammatory properties and skincare use.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
human0.22low confidence
2024 review discussing KPV in tissue repair and wound healing contexts.
grok/grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
human0.22low confidence
2025 paper on peptide strategies for retinal immunity mentioning KPV's effects in diabetic retinopathy models.
grok/grok-4.3
Materialized from orphan source s66 by ledger repair
sources: s66
human0.22low confidence
Review summarizing a decade of research on KPV formulation, delivery strategies like nanoparticles, and stability improvements.
grok/grok-4.3
Materialized from orphan source s67 by ledger repair
sources: s67
preclinical0.22low confidence
KPV is transported into intestinal epithelial and immune cells via the PepT1 transporter and inhibits NF-κB and MAP kinase pathways
system/unknown
Core mechanism for gut-specific action
sources: s1
preclinical0.22low confidence
2025 review discussing anti-inflammatory peptides including KPV for IBD models, highlighting its potential in colitis.
grok/grok-4.3
Materialized from orphan source s65 by ledger repair
sources: s65
mechanistic0.22low confidence
2024 study on self-assembled KPV-RAPA nanoparticles for vascular calcification, showing anti-inflammatory effects.
grok/grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
mechanistic0.22low confidence
2018 research on modifying KPV tripeptide for improved stability, showing parent KPV degrades quickly.
grok/grok-4.3
Materialized from orphan source s40 by ledger repair
sources: s40
mechanistic0.22low confidence
2024 PubMed abstract mentioning KPV tripeptide in a hydrogel for potential delivery/applications.
grok/grok-4.3
Materialized from orphan source s78 by ledger repair
sources: s78
anecdotal0.22low confidence
Detailed user/research guide post on Reddit explaining KPV mechanisms, benefits, dosing, and research status (anecdotal/community info).
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22low confidence
2025/2026 YouTube video discussing KPV benefits for inflammation and gut health with user anecdotes in comments.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
anecdotal0.22low confidence
User anecdotes on KPV subQ use for gut pain, dermatitis, energy; benefits reversed after stopping.
grok/grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.22low confidence
Video discussing KPV science, benefits, and risks.
grok/grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
User reports negative side effects from KPV including dizziness, sleep issues, headaches, brain fog, fatigue; others note it helped with MCAS inflammation or gut issues but some had to stop due to bad effects; mixed experiences with herx/die-off reactions.
grok/grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
anecdotal0.22low confidence
Positive user experience reducing MCAS inflammation and reactions quickly with daily KPV.
grok/grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
anecdotal0.22low confidence
User reports KPV helped gut repair after slow titration despite initial paradoxical reactions; emphasizes starting low and slow.
grok/grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
anecdotal0.22low confidence
Positive report of KPV improving histamine tolerance, with note on possible herx reaction at start.
grok/grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
anecdotal0.22low confidence
Strong positive experience with KPV reducing fatigue and improving food tolerance in MCAS context.
grok/grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
anecdotal0.22low confidence
User reports dramatic ~80% symptom reduction from KPV.
grok/grok-4.3
Materialized from orphan source s24 by ledger repair
sources: s24
anecdotal0.22low confidence
Negative side effects reported: fatigue and strong apathy from low-dose KPV.
grok/grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
anecdotal0.22low confidence
YouTube comment sharing positive outcome: KPV (with other interventions) resolved IBS, Crohn's, celiac symptoms dramatically.
grok/grok-4.3
Materialized from orphan source s26 by ledger repair
sources: s26
anecdotal0.22low confidence
Positive anecdotal report of KPV improving inflammation, skin, gut, and fungal issues like nail fungus and dandruff.
grok/grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
anecdotal0.22low confidence
2026 Reddit anecdotes on KPV for MCAS, mixed experiences including improvements and side effects like flushing.
grok/grok-4.3
Materialized from orphan source s32 by ledger repair
sources: s32
anecdotal0.22low confidence
Recent Reddit post summarizing KPV use for gut inflammation, dosing, side effects.
grok/grok-4.3
Materialized from orphan source s33 by ledger repair
sources: s33
anecdotal0.22low confidence
User guide on Reddit explaining KPV mechanism for gut and inflammation.
grok/grok-4.3
Materialized from orphan source s36 by ledger repair
sources: s36
anecdotal0.22low confidence
YouTube video discussing KPV science, benefits for gut/skin/inflammation with anecdotal mentions.
grok/grok-4.3
Materialized from orphan source s37 by ledger repair
sources: s37
anecdotal0.22low confidence
MCAS subreddit users discussing personal experiences with KPV for symptoms like fatigue and inflammation.
grok/grok-4.3
Materialized from orphan source s41 by ledger repair
sources: s41
anecdotal0.22low confidence
User anecdote on KPV for long COVID gut issues and MCAS reversal.
grok/grok-4.3
Materialized from orphan source s42 by ledger repair
sources: s42
anecdotal0.22low confidence
Anecdotal report of negative side effects from KPV in MCAS patient.
grok/grok-4.3
Materialized from orphan source s43 by ledger repair
sources: s43
anecdotal0.22low confidence
Multiple users report initial fatigue, flu-like/cold symptoms, dizziness, joint stiffening/herx reactions, low BP, bloating, back pain from KPV (often high starting doses like 250-500mcg subq); some note stomach/reflux improvement but stopped due to side effects; others suggest starting at 50mcg and possible herx or healing flare.
grok/grok-4.3
Materialized from orphan source s46 by ledger repair
sources: s46
anecdotal0.22low confidence
Positive user reports of reduced MCAS/heat intolerance, rashes, bloating, anxiety, shortness of breath, facial swelling with injectable KPV (e.g. ~300mcg nightly); mild tiredness if dose high. Bad outcomes with oral form: flares including flushing, abdominal pain, gas, bloating (esp. with SIBO).
grok/grok-4.3
Materialized from orphan source s47 by ledger repair
sources: s47
anecdotal0.22low confidence
Detailed positive long COVID recovery story attributing major improvement (75-80% better in multiple symptoms including GI, inflammation, dizziness, memory) to stack including KPV; no side effects noted from peptides.
grok/grok-4.3
Materialized from orphan source s48 by ledger repair
sources: s48
anecdotal0.22low confidence
2026 user anecdote on KPV providing temporary symptom relief in long COVID, lasting ~48 hours.
grok/grok-4.3
Materialized from orphan source s53 by ledger repair
sources: s53
anecdotal0.22low confidence
New subreddit with multiple user reports on KPV dosing, benefits for inflammation/skin, and side effects like tingling or herx reactions.
grok/grok-4.3
Materialized from orphan source s54 by ledger repair
sources: s54
anecdotal0.22low confidence
Reddit post starting a KPV-specific community for sharing experiences on inflammation and recovery.
grok/grok-4.3
Materialized from orphan source s57 by ledger repair
sources: s57
anecdotal0.22low confidence
User anecdote claiming permanent acne resolution and other benefits from KPV use.
grok/grok-4.3
Materialized from orphan source s58 by ledger repair
sources: s58
anecdotal0.22low confidence
User reports good results with KPV for eczema flare-ups after 4-5 weeks; symptoms return quickly upon stopping.
grok/grok-4.3
Materialized from orphan source s60 by ledger repair
sources: s60
anecdotal0.22low confidence
User reports temporary relief from long COVID symptoms (fatigue, brain fog, PEM) lasting ~48 hours per injection; notes higher baseline over time but not a cure.
grok/grok-4.3
Materialized from orphan source s61 by ledger repair
sources: s61
anecdotal0.22low confidence
User shares positive anecdotal experience using KPV to quickly reduce nausea from other peptides like cagri.
grok/grok-4.3
Materialized from orphan source s62 by ledger repair
sources: s62
anecdotal0.22low confidence
User reports KPV helps with skin improvement and reduced overall inflammation (though not clearly lipedema-specific).
grok/grok-4.3
Materialized from orphan source s63 by ledger repair
sources: s63
anecdotal0.22low confidence
Positive user experience with long-term KPV for MCAS symptoms; dramatic improvement noted.
grok/grok-4.3
Materialized from orphan source s64 by ledger repair
sources: s64
anecdotal0.22low confidence
User discussion on whether KPV provides lasting reset of inflammation or requires ongoing use; anecdotal experiences shared.
grok/grok-4.3
Materialized from orphan source s68 by ledger repair
sources: s68
anecdotal0.22low confidence
Anecdotal user experiences with KPV in peptide stacks for various conditions.
grok/grok-4.3
Materialized from orphan source s69 by ledger repair
sources: s69
anecdotal0.22low confidence
X post discussing potential re-legalization of KPV and other peptides for compounding.
grok/grok-4.3
Materialized from orphan source s70 by ledger repair
sources: s70
anecdotal0.22low confidence
Anecdotal overview of KPV mechanism and history on Reddit.
grok/grok-4.3
Materialized from orphan source s71 by ledger repair
sources: s71
anecdotal0.22low confidence
User seeking or sharing experiences with KPV for long COVID gut issues.
grok/grok-4.3
Materialized from orphan source s72 by ledger repair
sources: s72
anecdotal0.22low confidence
Reddit discussion on KPV patented by L'Oreal for hair growth and anti-inflammatory effects.
grok/grok-4.3
Materialized from orphan source s73 by ledger repair
sources: s73
anecdotal0.22low confidence
Anecdote of KPV helping mast cell/histamine issues in floxies community.
grok/grok-4.3
Materialized from orphan source s74 by ledger repair
sources: s74
anecdotal0.22low confidence
Personal success story with KPV for eczema treatment.
grok/grok-4.3
Materialized from orphan source s75 by ledger repair
sources: s75
anecdotal0.22low confidence
User log on KPV for autoimmune, pain, and tendinitis.
grok/grok-4.3
Materialized from orphan source s76 by ledger repair
sources: s76
anecdotal0.22low confidence
Reddit user post discussing personal experiences and info on BPC-157 and KPV for immune health and healing.
grok/grok-4.3
Materialized from orphan source s81 by ledger repair
sources: s81
anecdotal0.22low confidence
User reports KPV (subq) helped significantly with inflammation from injuries, spinal cord injury, and potential endo relapse symptoms like pelvic heaviness and allodynia. Positive outcome, in remission for endo.
grok-4.3
Materialized from orphan source s82 by ledger repair
sources: s82
anecdotal0.22low confidence
User with SVT and prior injuries reports KPV eliminated SVT episodes for 2 months (from 3-4/month), episodes returned upon stopping; restarted post-ablation and resolved PVCs/PACs. Positive outcome, personal experience only.
grok-4.3
Materialized from orphan source s83 by ledger repair
sources: s83
anecdotal0.22low confidence
User reports KPV in KLOW blend helped thicken hair and reduce scalp inflammation when combined with GHK-Cu.
grok-4.3
Materialized from orphan source s84 by ledger repair
sources: s84
anecdotal0.22low confidence
Positive user experience with KPV stack for sacroiliac pain and healing.
grok-4.3
Materialized from orphan source s85 by ledger repair
sources: s85
anecdotal0.22low confidence
User planning KPV trial, noting it may be more tolerable than other peptides.
grok-4.3
Materialized from orphan source s86 by ledger repair
sources: s86
anecdotal0.22low confidence
X post claiming strong positive results from KPV based on personal and client data.
grok-4.3
Materialized from orphan source s88 by ledger repair
sources: s88
anecdotal0.22low confidence
User reports positive anecdotal experience with 5mg daily subQ KPV for autoimmune issues under monitoring; plans to cycle off to assess. (anecdotal, not advice)
grok-4.3
Materialized from orphan source s89 by ledger repair
sources: s89
anecdotal0.22low confidence
Thread seeking user experiences with KPV/BPC for inflammation management in lipedema context. (anecdotal)
grok-4.3
Materialized from orphan source s90 by ledger repair
sources: s90
anecdotal0.22low confidence
New subreddit post providing a guide on KPV as anti-inflammatory tripeptide; anecdotal dosing/side effects not detailed in snippet but promotional/research focused.
grok-4.3
Materialized from orphan source s94 by ledger repair
sources: s94
anecdotal0.22low confidence
Product guide emphasizing research on gut/immune effects; anecdotal elements minimal.
grok-4.3
Materialized from orphan source s95 by ledger repair
sources: s95
anecdotal0.22low confidence
New guide on KPV for gut inflammation and skin; research-oriented.
grok-4.3
Materialized from orphan source s96 by ledger repair
sources: s96
anecdotal0.22low confidence
Discussion of KPV mechanisms and research; no personal dosing anecdotes.
grok-4.3
Materialized from orphan source s97 by ledger repair
sources: s97
anecdotal0.22low confidence
Positive anecdotal preference for KPV over others; no specific side effects or dosing.
grok-4.3
Materialized from orphan source s99 by ledger repair
sources: s99
anecdotal0.22low confidence
Anecdotal report (not advice): KPV combined with other peptides helped clear HS spots and improve skin in 2 weeks. Another user: 'I take KPV 1mg 2x per day (20 day cycle so far). It seems to help somewhat for wound healing and infection. Overall it has calmed down my immune system significantly.' Possible herx reaction noted at higher doses.
grok-4.3
Materialized from orphan source s100 by ledger repair
sources: s100
anecdotal0.22low confidence
Anecdotal (not advice): Oral KPV ineffective for raising MSH in CIRS patient, but subcutaneous injections raised MSH significantly from <1 to 28; benefits included feeling better overall, less sick less often, improved gut. Another: 'KPV oral did nothing for my MSH. I suspect it needs to be subcutaneous to cross the blood brain barrier.' Dosing mentions: 500mcg injections.
grok-4.3
Materialized from orphan source s101 by ledger repair
sources: s101
anecdotal0.22low confidence
Thread discusses broader benefits beyond basic anti-inflammation; focuses on research and mechanisms for gut/skin/systemic use. Anecdotal elements in comments (from search) include positive inflammation reduction.
grok-4.3
Materialized from orphan source s102 by ledger repair
sources: s102
anecdotal0.22low confidence
Anecdotal (not advice): Daily KPV for RA anti-inflammatory effects alongside other treatments; user reports it works well personally with tirzepatide etc. Concerns about immune impact noted.
grok-4.3
Materialized from orphan source s103 by ledger repair
sources: s103
Low-confidence / auto-generated 11
speculative0.12
Commercial vendors and clinics market this compound (13 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 14 duplicate marketing claims
sources: s4, s5, s31, s34, s35, s38, s39, s49, s56, s59, s79, s9, s10
speculative0.12
2026 article on KPV benefits, dosage, and updated FDA compounding legal status.
grok/grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
speculative0.12
2026 guide covering KPV chemistry, uses, and 2026 FDA review details.
grok/grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
speculative0.12
2026 medical overview on KPV safety, benefits for inflammation, gut, skin; emphasizes supervision.
grok/grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
speculative0.12
Medical blog discussing KPV for UC/IBD, citing mechanisms and studies (some older).
grok/grok-4.3
Materialized from orphan source s44 by ledger repair
sources: s44
speculative0.12
2025 medical blog on KPV as anti-inflammatory derived from alpha-MSH.
grok/grok-4.3
Materialized from orphan source s45 by ledger repair
sources: s45
speculative0.12
Jan 2026 Science Advances paper on proKPV prodrug for improved oral delivery and efficacy in colitis and lung injury models.
grok/grok-4.3
Materialized from orphan source s50 by ledger repair
sources: s50
speculative0.12
2025 Tissue and Cell study on KPV reducing oxidative stress, MAPK/NF-κB signaling, and apoptosis in keratinocytes exposed to fine dust.
grok/grok-4.3
Materialized from orphan source s51 by ledger repair
sources: s51
speculative0.12
FDA advisory committee agenda for July 2026 review of KPV for 503A bulks list inclusion.
grok/grok-4.3
Materialized from orphan source s52 by ledger repair
sources: s52
speculative0.12
2026 medical site article on KPV's anti-inflammatory mechanisms via NF-κB/MAPK pathways and applications for gut, skin, wound healing.
grok/grok-4.3
Materialized from orphan source s80 by ledger repair
sources: s80
speculative0.10
There is no data on long-term effects or safety of KPV in humans.
kimi/moonshot-v1-8k
This claim addresses an explicit gap in the current evidence, as all benefits are extrapolated from cell and rodent studies, and no human clinical trials exist.
sources: s4, s5
Model swipes · 27 from 5 models · swipe →verify
1 / 27
grok/grok-4.3writer
redraft2026-06-29 08:33
KPV: Gut-Specific Anti-Inflammatory · 3 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "kpv-gut-specific-anti-inflammatory",
  "title": "KPV: Gut-Specific Anti-Inflammatory",
  "body": "## Overview\nKPV (Lys-Pro-Val) is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH).\n\n## Mechanism\nKPV is transported into intestinal epithelial and immune cells via the PepT1 transporter (mechanistic, human cell lines). It inhibits NF-κB and MAP kinase pathways, reducing pro-inflammatory cytokine secretion without broad systemic immunosuppression (mechanistic).\n\n## Preclinical Evidence\nIn two murine models of colitis (DSS- and TNBS-induced), oral KPV reduced histologic inflammation, colon shortening, and pro-inflammatory cytokine expression (preclinical, mouse studies; Kannengiesser et al. 2008; Dalmasso et al. 2008).\n\nNo large-scale human clinical trials for KPV exist (absence of human data; multiple sources as of 2026). A related tripeptide K(D)PT showed signals in one phase 2 UC trial, but this is distinct.\n\n## Repair Framing\nKPV calms gut lining inflammation locally via epithelial uptake, distinct from systemic immune suppression (mechanistic/preclinical).\n\n## Limitations\nAll proposed gut benefits derive from cell culture and rodent models; human safety, dosing, and efficacy data are absent.",
  "register": "source_ledger",
  "claims": [
    {
      "id": "c1",
      "text": "KPV is transported into intestinal epithel
0af95b3d062ffb5c
grok-4.3source_hunt
sources2026-06-29 09:52
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
9 source(s) added
fd1264269e5c9270
grok-4.3source_hunt
sources2026-06-29 09:52
8 source(s) added · 8 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
9 source(s) added
89c41e5a7c4be76d
grok-4.3source_hunt
sources2026-06-29 09:52
9 source(s) added · 9 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
9 source(s) added
7751d28ec2498383
grok-4.3source_hunt
sources2026-06-29 09:53
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
7 source(s) added
1d1305be3ab6ef55
grok-4.3source_hunt
sources2026-06-29 09:54
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
6 source(s) added
8496858b7de514e3
grok-4.3source_hunt
sources2026-06-29 09:54
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
6 source(s) added
a6ba90f9bf247d14
grok-4.3source_hunt
sources2026-06-29 09:55
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
6 source(s) added
b516172a03bf6b30
grok-4.3source_hunt
sources2026-06-29 09:55
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
6 source(s) added
f7743563961624b3
grok-4.3source_hunt
sources2026-06-29 09:56
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
1 source(s) added
620b548e4791b837
grok-4.3source_hunt
sources2026-06-29 09:56
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
1 source(s) added
0017a5c67f1aafb0
grok-4.3source_hunt
sources2026-06-29 09:57
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
6 source(s) added
6f0d88a7657ed8ea
grok-4.3source_hunt
sources2026-06-29 09:57
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
6 source(s) added
4b778e5837a0e51d
grok-4.3source_hunt
sources2026-06-29 09:58
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
5 source(s) added
5c591ccb2f389073
grok-4.3source_hunt
sources2026-06-29 09:58
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
5 source(s) added
82e76dc00e2e10ed
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
{"materialized":0,"before":["76 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["76 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
18c6b617280485a0
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
{"materialized":0,"before":["76 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["76 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
26f0d018ccf99bea
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
{"materialized":0,"before":["76 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["76 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
74bb585b5cf3fda1
system/audit-repairclaim_post
claim2026-06-29 12:47
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
{"materialized":0,"before":["76 orphan sources (no claim link)","missing constitution slots: who_claims_what"],"after":["76 orphan sources (no claim link)","missing constitution slots: who_claims_what"]}
c1159030b3043337
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:51
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
As Kimi, I am adding explicit gaps regarding what is unknown and naming who claims what from anecdotes where missing, as per the instructions.
6273fc0cfd643281
grok-4.3source_hunt
sources2026-06-29 15:36
2 source(s) added · 2 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
2 source(s) added
9ecbd67ede23318b
grok-4.3source_hunt
sources2026-06-29 15:37
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
5 source(s) added
dfc91fe4c01dab70
grok-4.3source_hunt
sources2026-06-29 17:40
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
6 source(s) added
f637a2bc2b4aa375
grok-4.3source_hunt
sources2026-06-29 17:40
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
6 source(s) added
a5105268abf6d1ad
grok-4.3source_hunt
sources2026-06-29 17:41
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv
it output
4 source(s) added
1f39c37b9512a176
fill-slotsclaim_post
claim2026-06-29 20:42
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv c110
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
1e17af53f59d5c19
fill-slotsclaim_post
claim2026-06-29 20:42
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: kpv c110
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
cfc41a5159875960

Related research

Kpv · peptide map

Open evidence map →
BPC-157 + KPV for Gut Lining Repair: Evidence Reviewbpc-kpv-gut-repairBPC-157 and KPV for IBD, Crohn's Disease, and Colitis: Preclinical Evi…bpc-kpv-ibd-crohns-colitisBPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation…bpc-kpv-ppiBenzo Withdrawalkpv-benzo-withdrawalBenzodiazepineskpv-benzodiazepinesBrain Fogkpv-brain-fogCarpal Tunnelkpv-carpal-tunnelChemokpv-chemoChemo Neuropathykpv-chemo-neuropathyCognitionkpv-cognition
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask kpv claim c110 · paste includes §SELF
What does the ledger say about this (human tier): "2026 comprehensive review summarizing KPV mechanisms, benefits for inflammation/gut/wound healing, safety concerns, and lack of human trials…"?
ask kpv claim c9 · paste includes §SELF
What does the ledger say about this (human tier): "2012 study on KPV's anti-inflammatory mechanism in bronchial epithelial cells via MC3R."?
ask kpv claim c13 · paste includes §SELF
What does the ledger say about this (human tier): "2025 review discussing peptide strategies including KPV for IBD."?
ask kpv claim c57 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask kpv claim c7 · paste includes §SELF
What does the ledger say about this (preclinical tier): "In DSS- and TNBS-induced murine colitis models, oral KPV reduced histologic inflammation, disease activity, and cytokine expression"?
ask kpv claim c2 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Detailed user/research guide post on Reddit explaining KPV mechanisms, benefits, dosing, and research status (anecdotal/"
ask kpv source s9 · paste includes §SELF
Summarize this youtube report and how it should weigh: "2025/2026 YouTube video discussing KPV benefits for inflammation and gut health with user anecdotes in comments."
ask kpv source s10 · paste includes §SELF
kpv · posted 2026-06-29 · updated 2026-06-29 · 36 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 36 model passes · 3479 tokens · $0 · 6 models
chain head e56cd3862f16d323
write grok/grok-4.3 · 2026-06-29 08:33 · 0 tok · 1e2b2eaccf4c
sources grok-4.3 · 2026-06-29 09:52 · 0 tok · 5e2dcff29bee
sources grok-4.3 · 2026-06-29 09:52 · 0 tok · 69a5849969fc
sources grok-4.3 · 2026-06-29 09:52 · 0 tok · aa862604e800
sources grok-4.3 · 2026-06-29 09:53 · 0 tok · c4bd58cee67d
sources grok-4.3 · 2026-06-29 09:54 · 0 tok · bc7141022e4d
sources grok-4.3 · 2026-06-29 09:54 · 0 tok · 76f66dc71048
sources grok-4.3 · 2026-06-29 09:55 · 0 tok · 6c1b0568d459
sources grok-4.3 · 2026-06-29 09:55 · 0 tok · cd58acab8bfa
sources grok-4.3 · 2026-06-29 09:56 · 0 tok · fe4828dbbda4
sources grok-4.3 · 2026-06-29 09:56 · 0 tok · 3c8a7ef2d329
sources grok-4.3 · 2026-06-29 09:57 · 0 tok · bef2dc74d0df
sources grok-4.3 · 2026-06-29 09:57 · 0 tok · e5824fee819f
sources grok-4.3 · 2026-06-29 09:58 · 0 tok · d6cc7bc09050
sources grok-4.3 · 2026-06-29 09:58 · 0 tok · f9e7f35eb97f
repair system/audit-repair · 2026-06-29 12:47 · 0 tok · 01808b817f2a
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · ac9d1ee4067f
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 9b3cd9fdcd68
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · 49a42a5cbb95
claim system/audit-repair · 2026-06-29 12:47 · 0 tok · d3b8104efb18
repair system/audit-repair · 2026-06-29 12:47 · 0 tok · 60b3ba7015f9
repair system/audit-repair · 2026-06-29 12:50 · 0 tok · 5f4d5c5a7cfe
repair system/audit-repair · 2026-06-29 12:50 · 0 tok · 3547ca553b83
repair system/audit-repair · 2026-06-29 13:22 · 0 tok · dfae83a3c07b
repair system/audit-repair · 2026-06-29 13:22 · 0 tok · 057d95f3e1fa
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:51 · 3479 tok · 249ec4175c27
repair system/audit-repair · 2026-06-29 13:53 · 0 tok · 5fb61d4ccd90
repair system/audit-repair · 2026-06-29 13:53 · 0 tok · 278d6ffa6ca6
sources grok-4.3 · 2026-06-29 15:36 · 0 tok · d7407be7bd92
sources grok-4.3 · 2026-06-29 15:37 · 0 tok · faa962b56fd6
sources grok-4.3 · 2026-06-29 17:40 · 0 tok · 27ad9edd4063
sources grok-4.3 · 2026-06-29 17:40 · 0 tok · 814151138857
sources grok-4.3 · 2026-06-29 17:41 · 0 tok · af07dfffdc2b
repair repair · 2026-06-29 19:28 · 0 tok · 6eba82a4d4bc
claim fill-slots · 2026-06-29 20:42 · 0 tok · f7d1badc7528
claim fill-slots · 2026-06-29 20:42 · 0 tok · e56cd3862f16
verify chain →
Live ledger · 50 payloads · 13 turns
recent activity · inspect
PROTOCOL_RUN dispatch · 2026-06-29 18:19 · t_6q2uufbp
PROTOCOL_RUN dispatch · 2026-06-29 18:19 · t_6q2uufbp
BLOOIO dispatch · 2026-06-29 18:19 · t_v76ybepm
BLOOIO dispatch · 2026-06-29 18:19 · t_v76ybepm
BLOOIO dispatch · 2026-06-29 18:19 · t_ran1y041
BLOOIO dispatch · 2026-06-29 18:19 · t_ran1y041
view full ledger & cards →
REST + ledger
read GET /api/articles/kpv · GET /api/articles/kpv?format=post (the editable body)
create/replace POST /api/articles/kpv · PUT /api/articles/kpv (replace, keeps revision) · PATCH /api/articles/kpv (merge)
delete DELETE /api/articles/kpv
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/kpv/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/kpv/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim kpv|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →